학술논문
PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial
Document Type
Article
Author
Source
In: The Lancet Diabetes and Endocrinology . (The Lancet Diabetes and Endocrinology, March 2024, 12(3):174-183)
Subject
Language
English
ISSN
22138595
22138587
22138587